These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Divining the path to a successful European exit. Buch HK; Gustafsson AC; Drvota V; Sundberg CJ Nat Biotechnol; 2011 Mar; 29(3):205-7. PubMed ID: 21510008 [No Abstract] [Full Text] [Related]
7. Biotech financing retrenches in Q2. Lawrence S Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116 [No Abstract] [Full Text] [Related]
8. Biotech's wellspring-a survey of the health of the private sector in 2015. Huggett B Nat Biotechnol; 2016 Jun; 34(6):608-15. PubMed ID: 27281417 [No Abstract] [Full Text] [Related]
9. Enthusiasm cools in Q2. Lawrence S Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352 [No Abstract] [Full Text] [Related]
17. The rise of European venture capital for biotechnology. Howell M; Trull M; Dibner MD Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356 [No Abstract] [Full Text] [Related]
18. Stuck in the middle. Fuyuno I Nature; 2006 Jul; 442(7100):237. PubMed ID: 16855561 [No Abstract] [Full Text] [Related]
19. US credit crunch impacts biotech across the globe. Mitchell P Nat Biotechnol; 2008 Apr; 26(4):359-60. PubMed ID: 18391997 [No Abstract] [Full Text] [Related]